Peridex Shortage: What Providers and Prescribers Need to Know in 2026

Chlorhexidine gluconate 0.12% oral rinse (Peridex, PerioGard, Paroex) is one of the most commonly prescribed medications in general dentistry and periodontics. While a formal national shortage does not exist as of 2026, many dental practices are fielding calls from patients who are struggling to fill their prescriptions. This guide is designed to help providers understand the landscape and take proactive steps to support their patients.

Current Availability Status (2026)

As of 2026, chlorhexidine gluconate 0.12% oral rinse is not listed on the FDA Drug Shortages database. It is manufactured by multiple generic companies, which provides supply-chain resilience. However, individual pharmacies—especially independent or rural pharmacies—may experience localized stock fluctuations. These are typically resolved within 24–48 hours via standard wholesale distribution channels.

Why Patients Are Calling About Availability

When patients call your office saying they can't find Peridex, the root cause is usually one of the following:

Brand-vs-generic confusion: The patient is asking for "Peridex" by brand name when only the generic is on the shelf. Most pharmacies automatically dispense generic unless DAW is specified.

Insurance processing issues: Some dental prescriptions run into friction in pharmacy systems that expect physician (not dentist) DEA numbers. A dental NPI, not a DEA number, is the correct identifier for non-controlled medications like chlorhexidine.

Local stock gaps: A particular pharmacy is temporarily out of stock and the patient doesn't know where else to look.

Cost barriers: Patients without dental insurance may be surprised by the cash price and decide not to fill. Retail cash prices range from $15–$40; coupons can bring this to $9–$11.

Prescribing Best Practices to Minimize Friction

A few simple prescribing and communication habits can significantly reduce the rate of unfilled chlorhexidine prescriptions:

Write the generic name: Use "chlorhexidine gluconate 0.12% oral rinse" on the prescription rather than the brand name Peridex. This removes the brand-search barrier at the pharmacy.

Send e-prescriptions to preferred pharmacies: Partner with 1–2 reliable pharmacy partners in your area that you know stock chlorhexidine consistently, and route e-scripts there by default when appropriate.

Provide coupon information at point of care: Tell patients before they leave that GoodRx or SingleCare coupons can reduce the price to $9–$11. A physical card or QR code at checkout takes 10 seconds and prevents prescription abandonment.

Stock samples in-office: Keeping a supply of chlorhexidine rinse samples in the office allows you to bridge the gap for post-procedure patients who need the medication the same day.

Clinical Alternatives When Chlorhexidine Is Unavailable

In the rare circumstance that a patient truly cannot locate chlorhexidine gluconate within an acceptable timeframe, consider these clinical alternatives:

Essential oils mouthwash (Listerine): ADA-accepted; appropriate for mild gingivitis; OTC availability; no staining.

Cetylpyridinium chloride (CPC) mouthwash: OTC; some antiplaque benefit; less potent than chlorhexidine; appropriate for mild cases.

Povidone-iodine rinse (diluted): Some evidence for post-surgical antimicrobial rinse; short-term use only; not appropriate as an ongoing gingivitis treatment.

How medfinder Can Support Your Patients

medfinder is a service that calls pharmacies on behalf of your patients to locate medications in stock, then texts the results to the patient. For dental practices whose patients are frequently reporting difficulty filling prescriptions, recommending medfinder as a resource can reduce after-hours calls to your office and improve prescription fill rates. Learn more about the medfinder provider portal.

Monitoring the Situation

Providers should monitor the FDA Drug Shortages database for any change in chlorhexidine gluconate status. You can also track the American Dental Association (ADA) news alerts for supply chain advisories. See our patient-facing shortage update for the consumer-level overview.